Background and Objective: In order to characterize the β-adrenoceptor (AR) subtypes involved in agonist-stimulated relaxation of murine urinary bladder we studied the effects of (−)-isoprenaline and CL 316,243 on tonic contraction and spontaneous contractions in detrusor strips of wild-type (WT) and β 2 -AR knockout (β 2 -AR KO) mice.
INTRODUCTION
Standard therapy of overactive bladder syndrome consists of muscarinic receptor antagonists, but β 3 -AR agonists have recently been introduced as a promising alternative (Chapple et al., 2014) . Experimental studies of β-AR-mediated relaxation in isolated detrusor strips are complicated by species differences. While such relaxation of human detrusor is mediated predominantly if not exclusively by the β 3 -AR (for reference, see Wuest et al., 2009) , most studies in rats have reported an involvement of both β 2 -and β 3 -AR (Takeda et al., 2003; Uchida et al., 2005) . Subtypes involved in mouse bladder are controversial. While we have found that detrusor relaxation is mediated via β 2 -AR (Wuest et al., 2009; Propping et al., 2015a) , other authors have suggested β 3 -ARs as the relevant subtype (Deba et al., 2009) . Some of this discrepancy may be due to different experimental conditions, but another major issue is that the various drugs employed may actually not exhibit the assumed β-AR subtype selectivity (Cernecka et al., 2014) .
Irrespective of the debate on β-AR subtypes involved in detrusor relaxation in various species, it has been questioned whether a direct effect on detrusor smooth muscle cell tone indeed is the underlying cellular mechanism for in vivo inhibition of detrusor overactivity by β-AR agonists (Eastham et al., 2015) . This is based on the observation that concentrations of β 3 -AR agonists as for instance mirabegron to induce human detrusor strip relaxation are considerably higher (EC 50 ∼1.7 µM, Svalo et al., 2013) than the plasma concentrations at therapeutic doses (30-75 nM, Krauwinkel et al., 2012) . There is some evidence, that modulation of spontaneous contractions could represent an alternative target for the therapeutic effect of β 3 -AR agonists in overactive bladder syndrome. Pre-contracting isolated detrusor tissue with KCl or muscarinic agonists not only increases tonic tension but also induces irregular force oscillations of variable amplitude and frequency (spontaneous contractions, also referred to as "phasic contractions" or "microcontractions"; Gillespie et al., 2015a) Interestingly, spontaneous contractions of detrusor in rats are more sensitive to suppression by (−)-isoprenaline than nerve-mediated contractions evoked by electric field stimulation, but this may be mediated via β 1 -AR (Gillespie et al., 2015b) . β-AR subtypes mediating inhibition of spontaneous contractions in other species including mice have not been explored in a systematic manner. Therefore, we have examined which β-AR subtype mediates inhibition of murine detrusor tone and spontaneous contractions. To address this, we have used the general β-AR agonist (−)-isoprenaline and the β 3 -AR agonist CL 316,243 in KCl-precontracted strips of β 2 -AR knockout (β 2 -AR KO) mice and their wild-type (WT) controls with separate analysis of detrusor tone and spontaneous contractions. Our results confirm the importance of β 2 -ARs for murine detrusor relaxation and attenuation of spontaneous contractions, but also attest contribution of β 3 -ARs.
MATERIALS AND METHODS
The control experiments of the present study were performed in FVB/N-WT mice, which match the genetic background of β 2 -AR KO mice. The mice were bred in the Department of Pharmacology and Toxicology, University of Würzburg, Germany. All experiments were performed in accordance with the local authorities (permission number 24D-9168.24-1/2007-17 of the Regierungspräsidium Dresden and of the Regierung of Unterfranken permission number 55.2-2531.01-60/13, Germany) and comply with the European Commission Directive 86/609/EEC regarding the protection and welfare of animals used for experimental as well as scientific purposes.
Determination of β-AR Subtypes Expression in Mouse Detrusor
Male FVB/N-WT controls and β 2 -AR KO mice (24-40 weeks) were killed by cervical dislocation under CO 2 anesthesia, and urinary bladders and lungs were removed. The bladders were cut open and detrusor tissue and mucosa were dissected with sharp scissors and further processed separately. RNA was isolated from the tissue samples using the RNeasy R -Kit (Qiagen) and total RNA was reverse transcribed using Superscript II reverse transcriptase (Invitrogen). For cDNA amplification of β 1 -ARs, β 2 -ARs, β 3 -ARs and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a reaction mixture was used containing SsoFast EvaGreen Supermix (BioRad). Quantitative real-time PCR was performed using the C1000 Thermal Cycler CFX96 (BioRad) and the data was analyzed as previously described (Vidal et al., 2012) . Amplification conditions for RT-PCR were 15 s at (Evans et al., 1999; Chernogubova et al., 2005; Wuest et al., 2009; Vidal et al., 2012) 
Experimental Procedure for Measureing Detrusors Contractions and Relaxations
Characterization of mice: the WT and β 2 -AR KO mice had average body weights of 29 ± 3 g for WT (n = 55) and 28 ± 4 g for β 2 -AR KO mice (n = 49). Strips of mouse urinary bladder were dissected as described previously (Propping et al., 2015a,b) . Muscle strips with an intact mucosal layer (mean weight WT mice 2.9 ± 1.6 mg, n = 75 strips; β 2 -AR KO mice 2.4 ± 1.8 mg, n = 74, P = 0.26) were mounted in an organ bath filled with 5 ml of modified Tyrode solution of the following composition (in mM): NaCl 126.9, KCl 5.4, MgCl 2 1.05, CaCl 2 1.8, NaH 2 HPO 4 0.45, NaHCO 3 22, EDTA 0.04, ascorbic acid 0.2, glucose 5.6. Phentolamine (3 µM) and prazosin (1 µM) were added to block α-ARs. The solution in the bath was maintained at 37 • C, and was oxygenated by vigorously bubbling with carbogen (95% O 2 , 5% CO 2 ). The pH was 7.4. All drugs were obtained from the same sources and dissolved either in distilled water of dimethyl sulfoxide as in our previous study (Propping et al., 2015c) . The DMSO concentration in the bath did not exceed 0.3%. The detrusor strips were connected to an isometric force transducer (GM2; Föhr Medical Instruments, Seeheim/OberBeerbach Germany) and preloaded with 5 mN. After 30 min in the organ bath, tension was readjusted to 5 mN. Force of contraction was recorded with Chart 4.0TM (AD Instruments, Sydney, NSW, Australia). Tonic tension was analyzed as the increase of force produced by 40 mM KCl, measured from the lower limit of the "noise" produced by spontaneous activity under baseline conditions and in the presence of KCl. The amplitudes and the time integral of spontaneous contractions were analyzed during the 2-min period before the next concentration increase, using Chart software. Agonist-induced attenuation of spontaneous activity was expressed as integral in percent of control.
The preparations were allowed to equilibrate for at least 60 min. During this period, they were stimulated two consecutive times with KCl (40 mM, without osmotic compensation). After another 45 min of washout, the strips were pre-contracted by depolarization with 40 mM KCl. Relaxation was induced with cumulatively increasing concentrations of (−)-isoprenaline, CL 316,243 or forskolin. Relaxation was measured as the difference between minimum force prior to addition of agonist (steady state force) and force in the presence of the agonist, and was expressed in percent of the response to 10 µM forskolin added at the end of each experiment (= 100%). All β-AR subtype-selective blockers were added 30 min before the start of KCl pre-contraction and remained in the bath solution throughout the remainder of the experiment. The concentrations of antagonists were CGP 20712A 300 nM, ICI 118,551 50 nM (Wuest et al., 2009; Propping et al., 2015a) , and L748,337 100 nM to 10 µM (Deba et al., 2009) . 
Calculation of −logEC 50 Values
Concentration-response curves were constructed by nonlinear regression for each individual experiment by using Prism 5.0 R (GraphPad R Software, Inc., San Diego, CA, USA). The negative logarithm to the base of 10 of the molar concentration producing 50% of the maximum response (−logEC 50 [M] ) as well as the maximum response (E max ) were calculated and expressed as mean ± SD. Please note that the non-linear regression curves depicted in the figures were fitted to the mean values of the data.
In Schild plots, log(CR-1) was plotted versus log(molar concentration of antagonist), where CR stands for concentration ratio, i.e., the agonist concentration producing 50% of the maximum effect (EC 50 ) in the presence of the antagonist divided by the EC 50 of in the absence of antagonist (Schild, 1947) .
The pA 2 value as a measure of potency of a surmountable antagonist was extrapolated from a straight line with the slope of unity, given by the formula pA 2 = log(CR − 1) − log(antagonist concentration).
The same formula was used for calculating the apparent pA 2 values by substituting the experimental values for one concentration only.
Statistical Analysis
The results are represented as mean ± standard deviation (mean ± SD). A two-tailed t-test for unequal samples with different variances was used for two-group comparisons and was calculated with Prism 5.0 R (GraphPad R Software, Inc., San A quantitative analysis of the data is shown in Table 1 .
Diego, CA, USA). Analysis of variance (ANOVA) was used for multiple group comparison, followed by an additional Bonferroni comparison test where appropriate. P < 0.05 was regarded as significant.
RESULTS

Expression of β-AR Subtypes in Intact Murine Detrusor Muscle
Expression of the three β-AR subtypes was determined by RT-PCR and quantitative real-time PCR in intact detrusor tissue from WT and genetically modified animals in order to verify knock-out of β 2 -ARs and to check for any compensatory changes in expression of β 1 -and β 3 -ARs. Figure 1 shows that β 2 -ARs were only detectable in detrusor tissue from WT but not from β 2 -AR KO mice, and the same results were obtained in the respective lung tissues, which served as controls. Furthermore, β 1 -and β 3 -ARs were expressed in bladder and lung tissue from all animals ( Figure 1A) . Between WT and β 2 -AR KO mice there were no differences in expression levels of β 1 -and β 3 -ARs ( Figure 1B ).
Baseline and KCl-induced Detrusor Contractions in WT and β 2 -AR KO Mice
Depolarization of mouse detrusor strips with 40 mM KCl induced a rapid increase in tone and spontaneous activity, which stabilized within 45 min (Figure 2A) . Mean values of peak force (F peak ) increases were greater in strips from β 2 -AR KO (2.86 ± 1.34 mN/mg w.w., n = 7/7) than WT mice (1.42 ± 0.97 mN/mg w.w., n = 18/14; P < 0.05); steadystate tone (F ss ) was 1.57 ± 0.76 mN/mg w.w. β 2 -AR KO and 0.76 ± 0.28 mN/mg w.w. in WT (P < 0.05).
In the same detrusor strips the baseline amplitudes of spontaneous contractions and their time integrals were greater in β 2 -AR KO than in WT mice [amplitudes: 0.46 ± 0.34 mN/mg FIGURE 3 | Effects β-AR blockers on detrusor tone and time-integral of spontaneous activity after exposure to 40 mM KCl (CGP, 300 nM CGP 20712A; ICI, 50 nM ICI 118,551; L748,337, 100 nM L748,337). (A,B) Peak increase (F peak ) and steady-state increase in tone (F ss ), respectively, after exposure to 40 mM KCl from WT and β 2 -AR KO preparations. Please note the difference in scale. (C,D) Time-integral of spontaneous contractions from WT and β 2 -AR KO preparations; baseline time-integral before (C) and time-integral after (D) exposure to 40 mM KCl. Mean ± SD from number of experiments as indicated. * denotes P < 0.05 compared with control.
w.w. and 0.16 ± 0.13 mN/mg w.w., P < 0.05; integral: 18.34 ± 10.51 (mN/mg w.w.) * s, and 6.26 ± 3.74 (mN/mg w.w.) * s, P < 0.05]. After addition of KCl the integral for spontaneous detrusor activity increased significantly to 41.60 ± 39.78 (mN/mg w.w.) * s in β 2 -AR KO and to 10.30 ± 8.77 (mN/mg w.w.) * s in WT (P < 0.05; Figure 2B ).
The β 1 -AR blocker CGP 20712A (300 nM) had little effect on KCl-induced F peak and F ss in either mouse strain (Figure 3) , except for F ss in WT mice ( Figure 3B) . CGP 20712A did not affect spontaneous contraction integral neither at baseline nor after KCl (Figures 3C,D) . Exposure to the β 2 -AR blocker ICI 118,551 (50 nM) increased F peak and baseline spontaneous activity in strips from β 2 -AR KO mice. Responses to the β 3 -AR blocker L748,337 (100 nM) exhibited great variability, but appeared to increase F peak and F ss rather than spontaneous activity.
(−)-Isoprenaline-induced Detrusor Relaxation in WT and β 2 -AR KO Mice
Increasing concentrations of (−)-isoprenaline caused almost complete relaxation of tone, and attenuation of spontaneous activity in intact strips from WT and β 2 -AR KO mice (Figures 2C,D) . However, strips from β 2 -AR KO mice were significantly less sensitive by almost 2 log units. The −logEC 50 values for (−)-isoprenaline-induced relaxation of tone were 7.98 for WT and 6.00 for β 2 -AR KO mice (see Table 1 ). The respective values for the (−)-isoprenaline-induced attenuation of integral for spontaneous contractions were 8.39 ± 1.06 and 6.34 ± 0.63, and were not significantly different from the effect on relaxation of tone.
In detrusor strips from WT mice, CGP 20712A (300 nM) and L748,337 (100 nM) had little effect on the CRCs of (−)-isoprenaline, whereas the β 2 -AR blocker ICI 118,551 (50 nM) shifted the CRCs to higher (−)-isoprenaline concentrations by about 1.4 log units (Figure 4 , top panels). In β 2 -AR KO mice, the three β-AR blockers produced little effect on the CRCs of (−)-isoprenaline (Figures 4A-C) , and the small shift to the right with 100 nM L748,337 did not reach significance. All −logEC 50 and E max values are summarized in Table 1 . Spontaneous activity was attenuated by (−)-isoprenaline to a somewhat larger extent in β 2 -AR KO than WT strips (Figures 4D-F) . The effects of (−)-isoprenaline on spontaneous activity were not influenced by blocking β 1 -AR with CGP Comparison with respective control without any blocker: * P < 0.05. Pre-contraction by 40 mM KCl. −logEC 50 , negative logarithm of the concentration of agonist required for half-maximum relaxation in the absence or presence of extra drug; E max , maximum response to agonist expressed in percent of the response to 10 µM forskolin (= 100%); n, number of detrusor strips in number of mice. Figure 4D ). There was a trend for a shift in the CRC by the β 2 -AR blocker ICI 118,551 in WT strips ( Figure 4E ) and by the β 3 -AR blocker L748,337 in β 2 -AR KO strips ( Figure 4F ). Again, due to the large variability, the effects on spontaneous contractions were less clear than on tonic contraction. These findings confirm our previous observations (Wuest et al., 2009; Propping et al., 2013 Propping et al., , 2015a ) that β 2 -ARs are the major β-AR subtype mediating relaxation in WT detrusor strips. However, given the low affinity of L748,337 for murine β 3 -ARs (Cernecka et al., 2014) , the concentration of 100 nM L748,337 may not have been sufficient to block murine β 3 -AR. Therefore, higher L748,337 concentrations were employed to antagonize (−)-isoprenaline-mediated relaxation in WT detrusor (Figure 5) . With 10 µM L478,337, the CRC was clearly shifted to the right ( Figure 5C ). The results with 1 and 3 µM L748,557 were less consistent (Figures 5A,B) . Nevertheless, these findings suggest that β 3 -ARs may be involved to a larger extent than previously anticipated by us (Propping et al., 2015a) , but as suggested by Deba et al. (2009) . The Schild plot ( Figure 5D ) clearly deviated from unity suggesting a more complex mechanism than simple competition of (−)-isoprenaline and L748,337 for a single binding site. Fitting a linear regression of slope 1 to the data points, yielded a pA 2 value of 6.08 for L748,337 in strips from WT mice.
20712A (
CL 316,243-Induced Detrusor Relaxation in WT and β 2 -AR KO Mice
In order to resolve these different interpretations, we next investigated the effects of the β 3 -AR-selective agonist CL 316,243 that was employed by Deba et al. (2009) . Increasing concentrations of CL 316,243 relaxed detrusor strips from WT and β 2 -AR KO with similar potency and efficacy (Figure 6 ). In comparison with (−)-isoprenaline, CL 316,243 tended to be less potent in strips from WT than β 2 -AR KO mice (compare Figure 2, Table 1 ). Again, more vigorous spontaneous activity was observed in β 2 -AR KO than WT strips ( Figure 6B) . The complete CRCs revealed that detrusor strips relaxed less completely ( Figure 6C, Table 1 ) and that attenuation of spontaneous activity failed to reach significance both in WT and β 2 -AR KO strips ( Figure 6D) . Concentrations of 100-300 nM L748,337 had no significant effect on the CRCs for CL 316,243 under any experimental condition, but concentrations between 1 and 10 µM L748,337 induced complex changes in relaxation (Figures 7A,B) . In strips from WT mice, L748,337 did not shift the CRCs of CL 316,243, but with 3 and 10 µM L748,337 relaxation became more complete. In β 2 -AR KO mice, L748,337 caused a shift of the CRCs to higher concentrations of CL 316,243, in addition to more complete relaxation. Again, the Schild plot ( Figure 7C ) deviated from unity indicating a complex mechanism of interaction also between CL 316,243 and L748,337. Using a slope factor of 1, the pA 2 value was 6.70 for L748,337 in strips from β 2 -AR KO mice.
β-AR-independent Detrusor Relaxation by Forskolin in WT and β 2 -AR KO Mice
In order to estimate receptor-independent relaxation we have also studied the responses to adenylyl cyclase activation with forskolin (Morita et al., 1986) in WT and β 2 -AR KO mice (Figure 8) . Forskolin completely relaxed tonic tension ( Figure 8A ) and attenuated spontaneous contractions ( Figure 8B ) and there were no differences in sensitivity between strips from WT and β 2 -AR KO mice (Table 1) .
DISCUSSION
The aim of the present study was to investigate the β-AR subtypes involved in attenuating tonic and spontaneous contraction of murine detrusor in order to elucidate the discrepancy between our own results (Wuest et al., 2009; Propping et al., 2015a) and those of others (Deba et al., 2009 ) by utilizing β 2 -AR KO mice and β-AR subtype-selective ligands as pharmacological tools (Schmid et al., 2015) .
Regulation of detrusor contractility is complex and not fully understood. The central force-developing step in detrusor contraction is the interaction between myosin and actin filaments that occurs upon phosphorylation of myosin light chains (MLC) via Ca 2+ -calmodulin dependent MLC kinase (MLCK, Andersson and Arner, 2004; Hashitani et al., 2004) . Several signal transduction pathways are likely to be involved in β-AR-mediated smooth muscle relaxation. The canonical signaling pathway for β-AR involves stimulation of adenylyl cyclase, elevation of cellular cAMP levels and activation of protein kinase A (PKA). Activated PKA phosphorylates MLCK thereby impairing its Ca 2+ -calmodulin-dependent activation, which reduces MLC phosphorylation and hence muscle tone (Andersson and Arner, 2004; Hashitani et al., 2004) . β-ARmediated relaxation also involves Ca 2+ -activated K + channels of large conductance (BK Ca channels; Petkov, 2014) . Enhanced BK Ca channel activity via PKA-mediated phosphorylation may contribute to relaxation by hyperpolarizing the cell membrane and reducing Ca 2+ influx via voltage-dependent Ca 2+ channels FIGURE 5 | Effects of the β 3 -AR-selective blocker L748,337, 1 µM (A), 3 µM (B), and 10 µM (C), on CRCs for (−)-isoprenaline-induced relaxation of KCl-precontracted detrusor strips from WT mice. The control is taken from the same experiments as in Figure 2 . Mean values ± SD from n experiments as indicated in parenthesis (number of strips/number of animals). (D) Schild plot for determining the pA 2 value of L748,337 (see Materials and Methods for further details). (Wegener et al., 2004) . However, Frazier et al. (2005) questioned the role of cAMP in β-AR-mediated relaxation because inhibitors of adenylyl cyclase or PKA had limited effect on rat detrusor relaxation, suggesting that other unknown pathways are involved as well.
Which β-AR Subtype Mediates (−)-Isoprenaline-or CL 316,243-induced Murine Detrusor Relaxation?
Constitutive systemic knockout of a particular receptor subtype may cause compensatory changes in expression of other receptors or proteins (Michel and Seifert, 2015) . Therefore, the expression of all β-AR subtypes in detrusor tissue from WT and transgenic mice was checked using RT-PCR and quantitative real-time PCR. Despite cumulating evidence that GAPDH expression is decreased under conditions of increased sympathetic tone (Michel-Reher and Michel, 2015) we normalized the expression data to GAPDH as a housekeeping gene. In real-time PCR GAPDH remained constant (data not shown) so that we felt safe with this normalization. Our results clearly indicated complete absence of the β 2 -AR subtype, whilst compensatory expression of β 3 -(or β 1 -)ARs is absent in detrusor tissue from β 2 -AR KO mice.
Since the β 2 -AR KO mice were bred against a genetic background different from the previously used C57Bl6 mice, new control experiments had to be performed with FVB/N-WT mice. The results were similar as in C57Bl6 mice (Wuest et al., 2009; Propping et al., 2015a) , i.e., the β 2 -AR blocker ICI 118,557 significantly shifted the CRCs for (−)-isoprenaline to the right, confirming that β 2 -ARs are involved in this relaxing effect. The affinity estimate calculated for ICI 118,557 based on these shifts (apparent pA 2 values: 8.63) was in good agreement with its known affinity at β 2 -AR (for instance 8.92 and 8.8 for human β 2 -AR expressed in CHO cells, respectively, Tate et al., 1991; Palea et al., 2012) . In the absence of any β 2 -ARs in the KO animals, the detrusor relaxation response to (−)-isoprenaline could be mediated by β 1 -or β 3 -AR. Since β 1 -ARs are predominant only in guineapig urinary bladder (Yamamoto et al., 1998) , the relaxant effect of (−)-isoprenaline in the β 2 -AR KO mice must have been mediated via β 3 -ARs. The (−)-isoprenaline concentrations required for half-maximum relaxation were about ∼90-fold higher in detrusor from β 2 -AR KO than WT mice. Given the affinity of murine β 3 -ARs for (−)-isoprenaline, e.g., −logEC 50 5.57 (Blin et al., 1994) , this is indeed in the concentration range required for β 3 -AR activation. Furthermore, the selective β 3 -AR agonist CL 316,243 clearly produced relaxation in detrusor strips both from WT and β 2 -AR KO mice with similar −logEC 50 values which corresponded to the −logEC 50 value of 8.61 for CL 316,243 at rodent β 3 -AR (Clouse et al., 2007) .
The −logEC 50 value of (−)-isoprenaline for relaxation of WT mouse detrusor, i.e., 7.98 was about 1.5 orders of magnitude lower than its known affinity at mammalian β 2 -AR (pK i 6.4; www.guid etopharmacology.org). This finding suggests that there is a large receptor reserve for detrusor relaxation via β 2 -AR. When β 2 -AR are blocked with ICI 118,551 or are absent as in β 2 -AR KO mice, (−)-isoprenaline is able to relax mouse detrusor via β 3 -AR stimulation, but spare receptors do not appear to play a role in this case.
Although, small molecule inhibitors have been valuable tools to characterize receptor subtypes in pharmacological studies, the interpretation of such results is complicated because the compounds may exhibit non-anticipated receptor-activation patterns or lack of selectivity (Michel and Seifert, 2015) . In our previous work, we concluded that the relaxing effect of (−)-isoprenaline in murine detrusor was mediated via β 2 -ARs, because only ICI 118,551 (50 nM) shifted the CRCs for (−)-isoprenaline to the right, whereas the β 1 -AR blocker CGP 20712A (300 nM) and the β 3 -AR blocker L748,337 (100 nM) were without effect (Wuest et al., 2009; Propping et al., 2015a) . In contrast, based on experiments with CL 316,243 and with higher concentrations of L748,337 (1-10 µM), other groups reported that murine detrusor relaxes via activation of β 3 -ARs (Deba et al., 2009) . Our previous failure to detect a shift in (−)-isoprenaline CRCs by L748,337 (100 nM) in mouse detrusor may in retrospect be explained by the recent observation that L748,337 has 10-100-fold lower affinity to rodent than human β 3 -ARs (Palea et al., 2012; van Wieringen et al., 2013) . Some of these species differences in potency have been related to differences in the binding pocket for L748,337 between human and rodent β 3 -AR (Cernecka et al., 2014) .
In the present study we employed L748,337 concentrations up to 10 µM and found significant effects on both (−)-isoprenalineand CL 316,243-induced relaxation of detrusor from WT and β 2 -AR KO mice. In our previous work, Schild plot analysis revealed a surmountable antagonism between ICI 118,551 and (−)-isoprenaline (or adrenaline) in C57Bl6 murine detrusor and between L748,337 and (−)-isoprenaline (or noradrenaline) in human detrusor (Wuest et al., 2009; Propping et al., 2013) . However, the mode of antagonism by L748,337 seems to be more complex in the mouse. As expected, the antagonistic effect of L748,337 was most consistent in CL-316,243-stimulated detrusor from β 2 -AR KO mice, i.e., under conditions when relaxation was most likely produced by β 3 -AR activation.
Effects of β-AR Agonists on Spontaneous Activity
Although, spontaneous activity of detrusor muscle is not fully understood, increasing evidence suggests that smooth muscle cells posses intrinsic mechanisms for spontaneous contractions and that these are synchronized and modulated by interstitial cells distributed throughout the bladder wall (Davidson and McCloskey, 2005; Hashitani, 2006; Lagou et al., 2006) . Spontaneous activity in smooth muscle cells and interstitial cells is associated with intracellular Ca 2+ oscillations but appears to be generated by different mechanism as evidenced by different pharmacological responses (Johnston et al., 2008) . Here, we observed larger and more spontaneous c contractions in β 2 -AR KO than WT strips, and in addition, more spontaneous activity developed in β 2 -AR KO strips that were exposed to the β 2 -AR antagonist ICI 118,551. While the former finding could suggest adaptive responses to the chronic absence of β 2 -AR mediated signaling pathways, we do not have a plausible explanation for the latter puzzling finding, which needs to be verified in future studies in order to exclude random variation as an underlying cause. Attenuation of spontaneous contractions by (−)-isoprenaline occurred in the same concentration ranges in WT and β 2 -AR KO strips as relaxation of tonic tension, and the CRC was only shifted to the right by ICI118,551 suggesting a dominant role for β 2 -AR in this process. Nevertheless, the small attenuation of spontaneous activity by CL 316,243 indicates a modulating effect of β 3 -AR as well. Our findings do not confirm that suppression of phasic contractions by (−)-isoprenaline is most sensitive to β 1 -AR blockers (Gillespie et al., 2015b ), because we did not observe any shift in CRC with CGP 20712A. Taken together, comparison of the effects of subtype-selective β-AR agonists and antagonists suggests that tonic and spontaneous detrusor contractions may be modulated by different pathways but both β 2 -and β 3 -AR appear to be involved.
Effects of Forskolin
Relaxation of tonic and phasic detrusor contractions after receptor-independent activation of adenylyl cyclase with forskolin in WT and β 2 -AR KO mice were similar between the two groups. Furthermore, also after forskolin, spontaneous activity was suppressed less completely than tonic tension.
CONCLUSION
We have reported an example how false extrapolation of drug affinities for a given receptor subtype from different species can lead to an incomplete picture. Our novel findings in β 2 -AR KO mice suggest that there is a large receptor reserve for β 2 -AR so that this β-AR subtype will be activated preferentially by physiological ligands. Nevertheless β 3 -AR can also mediate relaxation and attenuate spontaneous contractions in the absence of β 2 -AR, when β 2 -AR are blocked or when selective β 3 -AR agonists are used.
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